Together these data suggest that tumoral iASPP-deficiency dampens the development of anti-tumor T cell responses while facilitating Treg infiltration and activation, abating anti-tumor immune responses and accelerating lung cancer development. The gene discussed is PPP1R13L; the disease is lung carcinoma.